Document is current

Article History

Received: 16 May 2024

Accepted: 16 September 2024

First Online: 5 November 2024

Declarations

:

: Denise Clayton is an employee of SSR Health, but was an employee of FTI Consulting during the time this study was conducted. FTI Consulting received funding from Novartis Pharmaceuticals Corporation, Inc. Jason Shafrin is employed by FTI Consulting, which received funding from Novartis Pharmaceuticals Corporation, Inc. Glorian P. Yen is employed by Novartis Pharmaceuticals Corporation, Inc. Lincy Geevarghese is employed by Novartis Pharmaceuticals Corporation, Inc. Yulin Shi is employed by KMK Consulting Inc. and receives funding from Novartis Pharmaceuticals Corporation, Inc. Anem Waheed consults for Novartis Pharmaceuticals Corporation, Inc, and receives funding from Novartis Pharmaceuticals Corporation, Inc.

: MarketScan data are de-identified and comply with the confidentiality requirements of the HIPAA. MarketScan data are collected as part of billing for routine patient care and deidentified before access is granted to researchers; therefore no Institutional Review Board review or patient consent was needed. The Observational Study was performed in accordance with the regulations and guidelines governing medical practice and ethics in the country of the Observational Study and in accordance with the Helsinki Declaration of 1964 and its later amendments, with currently acceptable techniques and know-how. Permission was obtained by all authors to access the MarketScan data used in this study.